Abstract Return on investment (ROI) analysis is increasingly being used for evaluating the value for money of public health interventions. Given its potential role for informing health policies, it is important that there is a more comprehensive understanding of ROI analysis within the global

Pritaporn Kingkaew BPharm, MSc*, Yot Teerawattananon MD, PhD* * Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand While many of the principles that guide the economic evaluation of medical devices are somewhat similar to those that guide the evaluation of other

Keywords: Health technology assessment, Rationale, Guideline development   Please follow the link below for full text. You may need to register (free-of-charge) as the article is published in Journal of the Medical Association of Thailand, Vol 91, No 6. http://www.jmatonline.com/index.

Background: Excessive intake of sodium is associated with elevated blood pressure, a risk factor that contributes to non-communicable diseases such as hypertension, chronic kidney disease, cardiovascular diseases, and stomach cancer. Interventions and policies to control population-wide salt intake

Executive Summary Digital health technology (DHT) offers the potential to expand universal health coverage (UHC) by answering healthcare needs through a wide range of technology applications for instance artificial intelligence, big data, and machine learning. The adoption of DHT is not a new con

Executive Summary Australia has a history of innovation, which is reflected in the breadth of health technologies that are increasingly available in the country’s digital health landscape. This breadth of digital health technologies can be categorised across four domains: Software as a Medical De

Executive Summary Digital health in Korea encompasses a wide range of technologies and services yet lacks a clear legal definition. The Korea Institute for Industrial Economics & Trade (KIET) classifies digital health into hardware, software, and service categories, reflecting the diverse lan

In Thailand, the prevalence of chronic kidney disease (CKD) is 17.5% of the population (Ingsathit et al., 2010). According to Thailand’s National Health Security Office (2021), in each year, this public health agency spends approximately 10,000 million Baht in renal dialysis and 1,000 million Baht f

Chronic kidney disease (CKD) is a life-threatening disease for many people. People suffering from such diseases need to undergo some form of kidney replacement therapy in order to live a long life. (1, 2) In 2019, it is estimated that 1.4 million people will die from chronic kidney disease worldwide